Basit öğe kaydını göster

Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings

dc.contributor.authorOral, Elif A.
dc.contributor.authorAkinci, Baris
dc.contributor.authorSubauste, Angela
dc.contributor.authorAjluni, Nevin
dc.contributor.authorEsfandiari, Nazanene H.
dc.contributor.authorMeral, Rasimcan
dc.contributor.authorNeidert, Adam H.
dc.contributor.authorBurant, Charles L.
dc.contributor.authorEraslan, Akin
dc.contributor.authorHench, Rita
dc.contributor.authorRus, Diana
dc.contributor.authorMckenna, Barbara
dc.contributor.authorHussain, Hero K.
dc.contributor.authorChenevert, Thomas L.
dc.contributor.authorTayeh, Marwan K.
dc.contributor.authorRupani, Amit R.
dc.contributor.authorInnis, Jeffrey W.
dc.contributor.authorMantzoros, Christos S.
dc.contributor.authorConjeevaram, Hari S.
dc.date.accessioned2022-02-18T08:59:12Z
dc.date.available2022-02-18T08:59:12Z
dc.date.issued2021
dc.identifier.citationAkinci B., Subauste A., Ajluni N., Esfandiari N. H. , Meral R., Neidert A. H. , Eraslan A., Hench R., Rus D., Mckenna B., et al., "Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings", MED, cilt.2, sa.7, ss.814-842, 2021
dc.identifier.othervv_1032021
dc.identifier.otherav_0eb29c78-20e6-4350-ba1d-7111d7789a03
dc.identifier.urihttp://hdl.handle.net/20.500.12627/176264
dc.identifier.urihttps://doi.org/10.1016/j.medj.2021.04.001
dc.description.abstractBackground: Recombinant leptin therapy reverses nonalcoholic steatohepatitis (NASH) in leptin-deficient lipodystrophy. We inquired if leptin therapy would improve NASH in more common forms of this heterogeneous condition.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectReviews and References (medical)
dc.subjectResearch and Theory
dc.subjectHealth Sciences
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.titleMetreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings
dc.typeMakale
dc.relation.journalMED
dc.contributor.departmentUniversity of Michigan System , ,
dc.identifier.volume2
dc.identifier.issue7
dc.identifier.startpage814
dc.identifier.endpage842
dc.contributor.firstauthorID3388291


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster